Slides
Page 1
59 190 232 49 143 171 91 72 187 252 199 0 0 160 217 6 183 198 No content left of this line Source and Footnotes Guideline Place content below this line Place content below this line No content left of this line No content right of this line CONFIDENTIAL No content right of this line TWSE-6919 Contact: ir@caliwaybiopharma.com 1 Investor Presentation TWSE：6919 2026/08/31
Page 2
59 190 232 49 143 171 91 72 187 252 199 0 0 160 217 6 183 198 No content left of this line Source and Footnotes Guideline Place content below this line Place content below this line No content left of this line No content right of this line CONFIDENTIAL No content right of this line This presentation has been prepared by Caliway Biopharmaceuticals Co., Ltd. (Code: 6919) (the “Company”), the content of this presentation is prepared with information available at the time of preparation, and summarizes the past, present, and future of the Company’s operations and activities based on subjective and objective assessments. This presentation contains forward-looking statements and are predictions, projections, and other statements about future events based on current expectations and assumptions. Such forward-looking statements may be affected by uncertainties, known and unknown risks, inferences, regulatory changes, changes in competitive environment, or other factors outside of the Company’s control which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements in this presentation. Caliway expressly disclaims to the fullest extent permitted by law any obligation or undertaking to provide any additional updates or revisions to any forward-looking statements contained herein to reflect any change in expectations or any change in events, conditions, or circumstances on which any such statements are based. The information provided in this presentation, including forward-looking statements, is based on numerous assumptions and the Company does not guarantee the accuracy or completeness of such information. No representation or warranty, express or implied, is made as to the accuracy, completeness, or reliability of the presentation and the information contained herein, and the information in this presentation does not purport to represent all of the Company’s results of operations, the industry, or future developments. The forward-looking statements in this presentation reflect the Company’s beliefs as of the date of this presentation, the Company undertakes no obligation to timely inform, update, or revise the information in this presentation if circumstances should change. The Company, its affiliates, directors, officers, employees, advisers, connected persons, or any other person disclaim all liability and responsibility for any direct or indirect loss or damage which may be suffered by any person through the use of or reliance on any information contained in this presentation. Confidentiality: This presentation and its contents are proprietary to the Company, and no part of the contents or its subject matter may be reproduced, redistributed, disseminated, or otherwise divulged, directly or indirectly, to any other person or published, in whole or in part, for any purpose without the prior written consent of the Company. 2 Disclaimer